Halifax's ABK Biomedical Secures $1.25M Financing Round
Halifax, Nova Scotia-based ABK Biomedical Inc., a medical device company focused on the treatment of uterine fibroids, a medical condition affecting 40% women over the age of 35, has secured funding totaling $1.25 million from investors based in Atlantic Canada. Venture capital firm Innovacorp accounted for a $250,000 equity investment, which is part of a larger financing round completed in late 2012. ABK will use the proceeds of these funds to further develop and market its products worldwide.
30 April 2013•3 mins read
